253 related articles for article (PubMed ID: 12356686)
21. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
22. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
23. Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization.
Honda K; Kanegane H; Eguchi M; Kimura H; Morishima T; Masaki K; Tosato G; Miyawaki T; Ishii E
Am J Hematol; 2000 Jun; 64(2):128-32. PubMed ID: 10814994
[TBL] [Abstract][Full Text] [Related]
24. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
25. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
Tangye SG
J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
[TBL] [Abstract][Full Text] [Related]
26. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
27. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
[TBL] [Abstract][Full Text] [Related]
28. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease.
Crotty S; McCausland MM; Aubert RD; Wherry EJ; Ahmed R
Blood; 2006 Nov; 108(9):3085-93. PubMed ID: 16788096
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
[TBL] [Abstract][Full Text] [Related]
30. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
[TBL] [Abstract][Full Text] [Related]
31. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
[TBL] [Abstract][Full Text] [Related]
32. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
[TBL] [Abstract][Full Text] [Related]
34. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
[TBL] [Abstract][Full Text] [Related]
35. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
Ma CS; Hare NJ; Nichols KE; Dupré L; Andolfi G; Roncarolo MG; Adelstein S; Hodgkin PD; Tangye SG
J Clin Invest; 2005 Apr; 115(4):1049-59. PubMed ID: 15761493
[TBL] [Abstract][Full Text] [Related]
36. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
37. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
Howie D; Sayos J; Terhorst C; Morra M
Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
[TBL] [Abstract][Full Text] [Related]
38. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
[TBL] [Abstract][Full Text] [Related]
39. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
